logo
Select company
Select metric
Ticker Information

Ticker

SCLX

Company Name

SCILEX HOLDING CO

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NASDAQ

SCILEX HOLDING CO - Capital Expenditures to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SCLX - CapEx/OCF Historical data
DateCapital ExpenditureCapital Expenditures to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ 00%$ 20.7M
3/31/2025$ 00%$ 15.96M
12/31/2024$ 00%$ 19.35M
9/30/2024$ 1K0.01%$ 11.43M
6/30/2024$ 22K0.18%$ 12.21M
3/31/2024$ 22K0%$ -3.57M
12/31/2023$ 30K0%$ -20.71M
9/30/2023$ 21K0%$ -16.04M
6/30/2023$ 7K0%$ -19.41M
12/31/2022$ 7K0%$ -21.26M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SCILEX HOLDING CO's latest trailing twelve months (TTM) CapEx/OCF stands at 0%.
  • Over the past 5 years, SCILEX HOLDING CO's average CapEx/OCF has been 0.09%.
  • The median CapEx/OCF for SCILEX HOLDING CO during this period was 0.09%
  • SCILEX HOLDING CO reached its highest CapEx/OCF over the past 5 years at 0.18%.
  • The lowest CapEx/OCF recorded by SCILEX HOLDING CO in the same timeframe 0.01%

SCILEX HOLDING CO's CapEx/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx/OCF Benchmarks
CompanyCapEx/OCF
SPRO : SPERO THERAPEUTICS INC -KRMD : KORU MEDICAL SYSTEMS INC -CELU : CELULARITY INC -LNSR : LENSAR INC -UTMD : UTAH MEDICAL PRODUCTS INC 2.36%IVVD : INVIVYD INC -THTX : THERATECHNOLOGIES INC 0.16%TLSI : TRISALUS LIFE SCIENCES INC -CVRX : CVRX INC -CCCC : C4 THERAPEUTICS INC -

Definition of Capital Expenditures to Operating Cash Flow

[Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for SCILEX HOLDING CO is calculated as follows: CapEx [ $ 0 ] / CF - Operations [ $ -1.28K ]
(=) CapEx/OCF [ 0% ]

SCLX - Capital Expenditures to Operating Cash Flow, Last 5 years

0.01%

Minimum

Sep 30, 2024

0.18%

Maximum

Jun 30, 2024

0.09%

Average

0.09%

Median

CapEx/OCF Benchmark Analysis

The chart above depicts the distribution of CapEx/OCF for companies in the Total Stock Market. The average CapEx/OCF of the companies is 31.8% with a standard deviation of 29.52%.
The following table provides additional summary stats:
CapEx/OCF in the Market:
filtered constituents2.35K
min0.01%
max128%
average31.8%
median22.41%
std29.52%